Poehling Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$5.28M |
| 2 |
Organon & Co
OGN
|
+$4M |
| 3 |
Warner Bros
WBD
|
+$3.1M |
| 4 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$2.99M |
| 5 |
Alibaba
BABA
|
+$2.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares Ultra Silver
AGQ
|
+$2.7M |
| 2 |
AB InBev
BUD
|
+$2.19M |
| 3 |
WPP
WPP
|
+$1.86M |
| 4 |
PepsiCo
PEP
|
+$1.36M |
| 5 |
Harley-Davidson
HOG
|
+$1.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 35.03% |
| 2 | Healthcare | 13.01% |
| 3 | Communication Services | 10.28% |
| 4 | Technology | 8.87% |
| 5 | Consumer Discretionary | 6.68% |
Similar funds
Poehling Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Poehling Capital Management held 166 positions worth $314M, up 9.9% from $286M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Poehling Capital Management deployed $12.9M of net new capital in Q2 2021, opening 9 new positions and adding to 51 existing holdings. Its largest new stake was Organon & Co: 121,470 shares worth $3.68M.
By sector, the portfolio is most concentrated in Financials at 35% of assets, down from 35% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was PepsiCo, an estimated $1.36M trimmed.
- Poehling Capital Management's largest Q2 2021 buy was Organon & Co: 121,470 shares worth $3.68M.
- Poehling Capital Management added most to Apple in Q2 2021, an estimated $5.28M increase.
- Poehling Capital Management's biggest Q2 2021 reduction was PepsiCo, cutting an estimated $1.36M.
- Poehling Capital Management fully exited ProShares Ultra Silver in Q2 2021, selling an estimated $2.7M.
- Poehling Capital Management's ten largest holdings make up 28% of its $314M portfolio in Q2 2021.
- Poehling Capital Management opened 9 new positions and closed 18 in Q2 2021.
- Poehling Capital Management's portfolio value rose 9.9% quarter-over-quarter to $314M.
Based on Poehling Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.